IDEAYA Biosciences, Inc. (IDYA)
Last updated: 2026-10-24 13:36:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
IDEAYA Biosciences, Inc. (IDYA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $34.70, with a market capitalization of $3.49B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $26.81 to $42.68. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$3.49B | |
$34.76 | |
$47.74 | |
$2.95 | |
$36.12 | |
83.32K | |
787.01K | |
-- | |
$42.68 | |
$26.81 | |
-- | |
-- |
IDEAYA Biosciences, Inc. (IDYA) Latest Closing Stock Price
IDEAYA Biosciences, Inc. (IDYA) last closed at $36.12 as of 2026-10-23 23:49:00, unchanged from the previous close of $36.12.
During the latest regular trading session, IDYA traded between $2.95 and $47.74, with a volume of 83.32K shares. The closing price was near the upper end and near the middle of its 52-week range.
IDEAYA Biosciences, Inc. (IDYA) 7-Day Stock Price Change
Over the past seven days, IDEAYA Biosciences, Inc. (IDYA) moved from $33.85 to $34.70, representing a gain of 2.51% ($0.85).
The stock traded between $32.72 and $36.35 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 872.89 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
IDYA 52-Week Price Position
Position in Range: 49.7%
IDYA is currently trading at $34.70, placing it 49.7% of the way from its 52-week low of $26.81 to its 52-week high of $42.68. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is IDEAYA Biosciences, Inc. (IDYA)?
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
IDEAYA Biosciences, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 145 |
| Exchange | NASDAQ |
| Company Website |
How to Buy IDEAYA Biosciences, Inc. (IDYA) Stock on MEXC
Eligible investors can buy real shares of IDEAYA Biosciences, Inc. (IDYA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is IDEAYA Biosciences, Inc. (IDYA) stock price today?
2.Is IDYA stock going up or down today?
3.What is IDYA pre-market price?
4.What is IDYA after-hours price?
5.Is IDYA stock trading now?
6.Where does IDYA sit relative to its 52-week high and low?
7.What sector is IDEAYA Biosciences, Inc. in?
8.What is IDEAYA Biosciences, Inc.'s market capitalization and where is it listed?
9.How is IDYA valued in terms of P/E ratio and EPS?
10.Does IDEAYA Biosciences, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
IDYA Stock Calculator
Estimate the value between IDYA shares and USD.
IDYA Shares to USD
1.00 IDYA shares = 34.701 USD
Calculations are estimates based on the latest available price and are for reference only.


